| 用途: |
Carbidopa is an aromatic-L-amino-acid decarboxylase inhibitor with an IC50 of 29 ± 2 μM. [1] It increases the plasma half-life of levodopa from 50 minutes to 1? hours. CarbiDOPA cannot cross the blood brain barrier, so it inhibits only peripheral DDC. It thus prevents the conversion of L-DOPA to dopamine peripherally. This reduces the side effects caused by dopamine on the periphery,besides, it increases the concentration of L-DOPA and dopamine in the brain. [2] br /[1] Gilbert JA et al. Clin Cancer Res. 2000 Nov;6(11):4365-72. |
VIP会员
![N-[3-(4-Amino-2-fluorophenoxy)propyl]-N,N-dimethylamine](https://yunshiji.oss-cn-shenzhen.aliyuncs.com/cas/221199-31-1.png "N-[3-(4-Amino-2-fluorophenoxy)propyl]-N,N-dimethylamine")
![[3-(1H-1,2,4-三唑-1-基)苯基]甲胺](https://yunshiji.oss-cn-shenzhen.aliyuncs.com/cas/741717-66-8.png "[3-(1H-1,2,4-三唑-1-基)苯基]甲胺")
粤公网安备44196802000105号
400-6226-992